BlackRock Inc. - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is and the CUSIP is 29664WAB1. A total of 22 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2023$1,053,690
+35.3%
2,046,000
+27.9%
0.00%
Q2 2023$779,040
+12.4%
1,600,000
-8.6%
0.00%
Q1 2023$693,175
-44.2%
1,750,000
-23.9%
0.00%
Q4 2022$1,242,000
-2.4%
2,300,0000.0%0.00%
Q3 2022$1,272,000
+1.7%
2,300,0000.0%0.00%
Q2 2022$1,251,000
+37.5%
2,300,000
+27.8%
0.00%
Q1 2022$910,000
-3.2%
1,800,0000.0%0.00%
Q4 2021$940,0001,800,0000.00%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q2 2022
NameSharesValueWeighting ↓
PenderFund Capital Management Ltd. 29,679,000$23,720,0007.42%
SILVERBACK ASSET MANAGEMENT LLC 11,750,000$6,487,1750.92%
DCF Advisers, LLC 1,550,000$884,0000.57%
Context Capital Management, LLC 14,764$8,274,0000.56%
AGF Investments LLC 7,000,000$3,872,0000.36%
WHITEBOX ADVISORS LLC 19,600,000$10,682,0000.30%
Pentwater Capital Management LP 46,411,000$26,134,0000.29%
TENOR CAPITAL MANAGEMENT Co., L.P. 20,000,000$11,591,0000.27%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 24,000,000$13,275,0000.24%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 14,900,000$8,493,0000.12%
View complete list of ESPERION THERAPEUTICS INC NE shareholders